Louis Elan D, Rios Eileen, Pellegrino Kathryn M, Jiang Wendy, Factor-Litvak Pam, Zheng Wei
GH Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Neurotoxicology. 2008 May;29(3):460-5. doi: 10.1016/j.neuro.2008.02.013. Epub 2008 Mar 18.
Harmane (1-methyl-9H-pyrido[3,4-b]indole), a neurotoxin, may be an environmental risk factor for essential tremor (ET). Harmane and related chemicals are toxic to the cerebellum. Whether it is through this mechanism (cerebellar toxicity) that harmane leads to ET is unknown. Impaired olfaction may be a feature of cerebellar disease.
To determine whether blood harmane concentrations correlate with olfactory test scores in patients with ET.
Blood harmane concentrations were quantified using high performance liquid chromatography. Odor identification testing was performed with the University of Pennsylvania Smell Identification Test (UPSIT).
In 83 ET cases, higher log blood harmane concentration was correlated with lower UPSIT score (rho=-0.46, p<0.001). 25/40 (62.5%) cases with high log blood harmane concentration (based on a median split) had low UPSIT scores (based on a median split) vs. 12/43 (27.9%) ET cases with low log blood harmane concentration (adjusted odd ratios (OR) 4.04, 95% confidence intervals (CI) 1.42-11.50, p=0.009). When compared with the low log blood harmane tertile, the odds of olfactory dysfunction were 2.64 times higher in cases in the middle tertile and 10.95 times higher in cases in the high tertile. In 69 control subjects, higher log blood harmane concentration was not correlated with lower UPSIT score (rho=0.12, p=0.32).
Blood harmane concentrations were correlated with UPSIT scores in ET cases but not controls. These analyses set the stage for postmortem studies to further explore the role of harmane as a cerebellar toxin in ET.
哈尔满(1-甲基-9H-吡啶并[3,4-b]吲哚)是一种神经毒素,可能是特发性震颤(ET)的环境风险因素。哈尔满及相关化学物质对小脑有毒性。哈尔满是否通过这种机制(小脑毒性)导致ET尚不清楚。嗅觉受损可能是小脑疾病的一个特征。
确定ET患者血液中哈尔满浓度与嗅觉测试分数是否相关。
采用高效液相色谱法定量血液中哈尔满浓度。使用宾夕法尼亚大学嗅觉识别测试(UPSIT)进行气味识别测试。
在83例ET患者中,血液哈尔满浓度对数越高,UPSIT分数越低(rho=-0.46,p<0.001)。25/40(62.5%)血液哈尔满浓度对数高的病例(基于中位数分割)UPSIT分数低(基于中位数分割),而12/43(27.9%)血液哈尔满浓度对数低的ET病例(调整后的优势比(OR)为4.04,95%置信区间(CI)为1.42-11.50,p=0.009)。与血液哈尔满浓度对数低的三分位数相比,中间三分位数病例嗅觉功能障碍的几率高2.64倍,高三分位数病例高10.95倍。在69名对照受试者中,血液哈尔满浓度对数越高,与UPSIT分数越低无关(rho=0.12,p=0.32)。
ET患者血液中哈尔满浓度与UPSIT分数相关,而对照受试者则不然。这些分析为尸检研究奠定了基础,以进一步探索哈尔满作为小脑毒素在ET中的作用。